510 related articles for article (PubMed ID: 17360832)
21. Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humans.
Vermeir M; Naessens I; Remmerie B; Mannens G; Hendrickx J; Sterkens P; Talluri K; Boom S; Eerdekens M; van Osselaer N; Cleton A
Drug Metab Dispos; 2008 Apr; 36(4):769-79. PubMed ID: 18227146
[TBL] [Abstract][Full Text] [Related]
22. Excretion and biotransformation of cisapride in rats after oral administration.
Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Mostmans E; Swysen E; Bracke J; Knaeps A; Heykants J
Drug Metab Dispos; 1988; 16(3):410-9. PubMed ID: 2900733
[TBL] [Abstract][Full Text] [Related]
23. Excretion and biotransformation of cisapride in dogs and humans after oral administration.
Meuldermans W; Van Peer A; Hendrickx J; Lauwers W; Swysen E; Bockx M; Woestenborghs R; Heykants J
Drug Metab Dispos; 1988; 16(3):403-9. PubMed ID: 2900732
[TBL] [Abstract][Full Text] [Related]
24. Disposition of lasofoxifene, a next-generation selective estrogen receptor modulator, in healthy male subjects.
Prakash C; Johnson KA; Gardner MJ
Drug Metab Dispos; 2008 Jul; 36(7):1218-26. PubMed ID: 18372400
[TBL] [Abstract][Full Text] [Related]
25. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
[TBL] [Abstract][Full Text] [Related]
26. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S
Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052
[TBL] [Abstract][Full Text] [Related]
28. Excretion, metabolism, and pharmacokinetics of CP-945,598, a selective cannabinoid receptor antagonist, in rats, mice, and dogs.
Miao Z; Scott DO; Griffith DA; Day R; Prakash C
Drug Metab Dispos; 2011 Dec; 39(12):2191-208. PubMed ID: 21875952
[TBL] [Abstract][Full Text] [Related]
29. Metabolic disposition of casopitant, a potent neurokinin-1 receptor antagonist, in mice, rats, and dogs.
Miraglia L; Pagliarusco S; Bordini E; Martinucci S; Pellegatti M
Drug Metab Dispos; 2010 Oct; 38(10):1876-91. PubMed ID: 20622044
[TBL] [Abstract][Full Text] [Related]
30. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
[TBL] [Abstract][Full Text] [Related]
31. Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers.
Paulson SK; Hribar JD; Liu NW; Hajdu E; Bible RH; Piergies A; Karim A
Drug Metab Dispos; 2000 Mar; 28(3):308-14. PubMed ID: 10681375
[TBL] [Abstract][Full Text] [Related]
32. Metabolism, pharmacokinetics, and excretion of a nonpeptidic substance P receptor antagonist, ezlopitant, in normal healthy male volunteers: characterization of polar metabolites by chemical derivatization with dansyl chloride.
Prakash C; O'Donnell J; Khojasteh-Bakht SC
Drug Metab Dispos; 2007 Jul; 35(7):1071-80. PubMed ID: 17431029
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and metabolism of nateglinide in humans.
Weaver ML; Orwig BA; Rodriguez LC; Graham ED; Chin JA; Shapiro MJ; McLeod JF; Mangold JB
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):415-21. PubMed ID: 11259325
[TBL] [Abstract][Full Text] [Related]
34. Disposition and biotransformation of the antiretroviral drug nevirapine in humans.
Riska P; Lamson M; MacGregor T; Sabo J; Hattox S; Pav J; Keirns J
Drug Metab Dispos; 1999 Aug; 27(8):895-901. PubMed ID: 10421616
[TBL] [Abstract][Full Text] [Related]
35. Structural elucidation of human oxidative metabolites of muraglitazar: use of microbial bioreactors in the biosynthesis of metabolite standards.
Zhang D; Zhang H; Aranibar N; Hanson R; Huang Y; Cheng PT; Wu S; Bonacorsi S; Zhu M; Swaminathan A; Humphreys WG
Drug Metab Dispos; 2006 Feb; 34(2):267-80. PubMed ID: 16280454
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and brain penetration of casopitant, a potent and selective neurokinin-1 receptor antagonist, in the ferret.
Minthorn E; Mencken T; King AG; Shu A; Rominger D; Gontarek RR; Han C; Bambal R; Davis CB
Drug Metab Dispos; 2008 Sep; 36(9):1846-52. PubMed ID: 18556439
[TBL] [Abstract][Full Text] [Related]
37. Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects.
Teng R; Oliver S; Hayes MA; Butler K
Drug Metab Dispos; 2010 Sep; 38(9):1514-21. PubMed ID: 20551239
[TBL] [Abstract][Full Text] [Related]
38. Disposition and metabolism of [14C]SB-649868, an orexin 1 and 2 receptor antagonist, in humans.
Renzulli C; Nash M; Wright M; Thomas S; Zamuner S; Pellegatti M; Bettica P; Boyle G
Drug Metab Dispos; 2011 Feb; 39(2):215-27. PubMed ID: 21045199
[TBL] [Abstract][Full Text] [Related]
39. Absorption, metabolism and excretion of ketanserin in man after oral administration.
Meuldermans W; Hendrickx J; Woestenborghs R; Van Peer A; Lauwers W; De Cree J; Heykants J
Arzneimittelforschung; 1988 Jun; 38(6):789-94. PubMed ID: 3178919
[TBL] [Abstract][Full Text] [Related]
40. Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat.
Matsui K; Mishima M; Nagai Y; Yuzuriha T; Yoshimura T
Drug Metab Dispos; 1999 Dec; 27(12):1406-14. PubMed ID: 10570021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
